To examine associations between the inflammatory marker C-reactive protein (CRP) measured preoperatively and on postoperative day 2 (POD2) and delirium incidence, duration, and feature severity. DESIGN: Prospective cohort study. SETTING: Two academic medical centers. PARTICIPANTS: Adults aged 70 and older undergoing major noncardiac surgery (N = 560). MEASUREMENTS: Plasma CRP was measured using enzyme-linked immunosorbent assay. Delirium was assessed from Confusion Assessment Method (CAM) interviews and chart review. Delirium duration was measured according to number of hospital days with delirium. Delirium feature severity was defined as the sum of CAM-Severity (CAM-S) scores on all postoperative hospital days. Generalized linear models were used to examine independent associations between CRP (preoperatively and POD2 separately) and delirium incidence, duration, and feature severity; prolonged hospital length of stay (LOS, >5 days); and discharge disposition. RESULTS: Postoperative delirium occurred in 24% of participants, 12% had 2 or more delirium days, and the mean AE standard deviation sum CAM-S was 9.3 AE 11.4. After adjusting for age, sex, surgery type, anesthesia route, medical comorbidities, and postoperative infectious complications, participants with preoperative CRP of 3 mg/L or greater had a risk of delirium that was 1.5 times as great (95% confidence interval (CI) = 1.1-2.1) as that of those with CRP less than 3 mg/L, 0.4 more delirium days (P < .001), more-severe delirium (3.6 CAM-S points higher, P < .001), and a risk of prolonged LOS that was 1.4 times as great (95% CI = 1.1-1.8). Using POD2 CRP, participants in the highest quartile (≥235.73 mg/L) were 1.5 times as likely to develop delirium (95% CI = 1.0-2.4) as those in the lowest quartile (≤127.53 mg/L), had 0.2 more delirium days (P < .05), and had more severe delirium (4.5 CAM-S points higher, P < .001). CONCLUSION: High preoperative and POD2 CRP were independently associated with delirium incidence, duration, and feature severity. CRP may be useful to identify individuals who are at risk of developing delirium. J Am Geriatr Soc 65:e109-e116, 2017.
D
elirium is characterized by acute change and fluctuations in attention, thinking, and consciousness. It occurs in 12% to 51% of individuals undergoing surgery, 1 and delirium after major surgery has been associated with longer hospitalization, 2 higher rates of discharge to nursing homes, 3 worse postoperative complications, 4 and higher in-hospital mortality. 2, 5 Despite knowledge of its epidemiology, delirium remains a purely clinical diagnosis, with no biomarkers to inform risk, diagnosis, or monitoring. Delirium is frequently present in conditions in which a systemic inflammatory response occurs, and there is growing evidence supporting a link between inflammation markers and delirium in varied settings. For instance, delirium has been associated with higher levels of proinflammatory cytokines in surgical and medical patients. 6, 7 Delirium has also been associated with proteins involved in the stress response, including one of the most commonly examined markers of systemic inflammation, the acutephase reactant C-reactive protein (CRP), [8] [9] [10] [11] [12] [13] [14] [15] but these studies have been limited in that they used relatively small samples of participants who had been admitted to medical wards, had experienced a cerebrovascular accident, or had undergone hip and vascular surgery. Furthermore, most studies examined CRP at only a single time point after participants became ill and thus lacked a true premorbid baseline measure of CRP. In addition, most studies focused solely on the association between CRP and delirium incidence. No study has addressed whether additional delirium-related outcomes, such as delirium duration and feature severity, and important clinical outcomes previously associated with delirium (including hospital length of stay (LOS) and discharge to a post-acute facility (discharge to a nursing home, rehabilitation, or subacute facility)) are linked to CRP.
Previous work in a nested, matched case-control subset of the Successful Aging after Elective Surgery (SAGES) cohort demonstrated that higher CRP levels before surgery and on Postoperative Day 2 (POD2) could predict postoperative delirium in older adults. 16 This research has been extended by examining the associations between CRP and postoperative delirium incidence, duration, and feature severity; LOS; and discharge disposition in the entire SAGES study cohort.
METHODS

Study Sample
The SAGES Study is a prospective observational study focused on elucidating novel risk factors, including biomarkers, of delirium and its associated long-term cognitive and functional decline. 17, 18 Between 2010 and 2013, SAGES enrolled 560 adults without dementia aged 70 and older scheduled for major, elective, noncardiac surgery. Major inclusion and exclusion criteria have been previously published. 17 Individuals with dementia were excluded from SAGES using a previously reported detailed, sequential screening process. 17 Informed consent for study participation was obtained from all subjects according to procedures that the institutional review boards of Beth Israel Deaconess Medical Center and Brigham and Women's Hospital, the two surgical sites, and Hebrew SeniorLife, the study coordinating center, all located in Boston, Massachusetts, approved.
Specimen Collection
All participants underwent serial blood collection preoperatively and on POD2. When possible, the sampling was incorporated into clinical blood draws taken in the preadmitting testing center before surgery (preoperatively) and on the surgical wards (POD2). During phlebotomy, mechanical disruption was minimized to prevent hemolysis or platelet activation. Blood was stored on ice in heparinized tubes until processing. During processing, lowspeed centrifugation was used to separate plasma from cellular material, and plasma was stored at -80°C until laboratory analysis. Nearly all samples satisfied rigorous quality control standards (99%), including 4 hours or less between blood draw and processing. Phlebotomy was performed on average 2 weeks before the index surgery (mean 13 AE 15 days).
18
CRP Enzyme-Linked Immunosorbant Assay CRP before surgery and on POD2 was measured in the entire SAGES sample using a high-sensitivity enzymelinked immunosorbent assay (ELISA) kit (R&D Systems; Minneapolis, MN), with all standards and samples run in duplicate. Each 96-well plate contained the standard curve and cases and controls at both timepoints. Coefficient of variations (CVs) of duplicate measures were generally 5% or less. If any CV was greater than 10%, that plasma sample was repeated. There was an internal calibrator sample for preoperative and POD2 time points on every 96-well ELISA plate. The cross-plate variation was consistently below the range of 5% to 10% based on the internal calibrator value. ELISA plates were read using a BioTek MX plate reader at an optical density of 450. A four-parameter logistic curve was used with final calculations determined in a spreadsheet template containing built-in macros for optimizing the best-fit model (http://www.rheumatologieneuss.net/index-Dateien/RheumatologieNeuss13.htm).
Delirium
Presence of postoperative delirium was determined from daily interviews from POD1 until hospital discharge, supplemented by a validated chart review method. 19 Trained study staff conducted structured cognitive assessments of attention, orientation, and memory. Delirium, assessed using the Confusion Assessment Method (CAM) diagnostic algorithm, was defined as having an acute onset of change or fluctuating mental status, inattention, and disorganized thinking or altered level of consciousness. 20, 21 At least two delirium experts (Sharon K. Inouye and Edward R. Marcantonio) adjudicated presence of delirium according to chart review, and discordance was resolved by consensus. 22 Participants were considered delirious if delirium was present according to the CAM (score based on the daily interview) or the chart review method on any POD; otherwise, they were considered not delirious. 18, 19 Delirium Duration and Feature Severity
Associations between CRP and delirium duration and feature severity were also examined. Delirium duration was determined by summing the total number of PODs the participant was considered to be delirious according to the CAM or chart review methods from the day after surgery until hospital discharge. Delirium feature severity was quantified using the CAM-Severity long form (CAM-S LF) score, 23 which is the sum of severity ratings of 10 CAM features (range 0-19, 19 most severe), each scored as 0 (absent), 1 (present, mild), or 2 (present, marked), except for fluctuating course, which is scored 0 (absent) or 1 (present). The primary outcome for delirium feature severity was defined as the sum of all CAM-S scores (sum CAM-S), which considers intensity and duration and thus reflects the total burden of delirium features over the entire hospitalization. Sum CAM-S was previously described and found to be the delirium feature severity measure most strongly associated with clinical outcomes. 23 In supplementary analyses, peak CAM-S score, defined as the highest CAM-S score on any postoperative day, an alternate delirium feature severity measure previously associated with clinical outcomes, was examined. 24 
LOS and Discharge Disposition
To examine the predictive validity of CRP for clinical outcomes related to delirium, its relationship with hospital LOS and discharge to a post-acute facility was examined. Prolonged LOS (>5 days; average LOS 5.2 days) and discharge to a post-acute facility were determined from medical record review. No participants resided in a nursing home before surgery.
Baseline Sample Characteristics
Baseline information was collected on education and cognitive performance. Total years of education was measured according to participant self-report. Preoperative cognitive functioning was measured using the general cognitive performance, a composite variable of commonly used neuropsychological measures. 25 Medical record review was used to gather information on comorbidities. 26 
Potential Confounders
Analytic models adjusted for the following: age, sex, surgical procedure, anesthesia route, Charlson Comorbidity Index (which includes preoperative connective tissue disease), and postoperative infectious complications. Surgical procedures were categorized into three types: orthopedic, vascular, and colorectal. 17, 18 Medical records were reviewed to obtain information on preoperative comorbidities (e.g., connective tissue disease), anesthesia route (general or spinal), and postoperative complications. Three physicians further verified and adjudicated postoperative infectious complications (urinary tract infection, pneumonia, wound infection). Postoperative medications were not controlled for because of the risk of overcontrolling for variables potentially along the causal pathway to delirium.
35,36
Statistical Analysis
Generalized linear models (GLMs) with a log-link and normal error distribution were used to determine the association between CRP (preoperative and POD2) and delirium incidence, prolonged LOS, and discharge to a post-acute facility. GLMs with an identity-link and normal error distribution were used for delirium duration and feature severity. For all outcomes, separate analytical models were used to examine postoperative delirium risk, duration, feature severity; prolonged LOS; and discharge to a postacute facility by considering CRP quartiles before surgery and on POD2 based on the SAGES sample distribution. For preoperative CRP, a CRP cutpoint previously validated to indicate high risk for cardiovascular disease (≥3 mg/L) was also examined. 27 A high-risk cutpoint analysis could not be completed for CRP at POD2 because postoperative CRP levels were much higher than in community-based samples. All reported analytical models were adjusted for age, sex, surgery type, anesthesia route, preoperative Charlson Comorbidity Index, and postoperative infectious complications.
Consideration of Subsyndromal Delirium
The association between CRP (preoperative and POD2) and a three-level outcome (delirium, subsyndromal delirium (SSD), no delirium) was further considered. (Appendix 1 includes detailed methods.)
Added Value of CRP in Predicting Delirium Risk
The added value of CRP preoperatively and on POD2 to an existing delirium risk prediction tool, the Inouye delirium risk score, was investigated. 28 (Appendix 2 includes detailed methods.)
All analyses were conducted in SAS version 9.3 (SAS Institute, Inc., Cary, NC). Table 1 reports the clinical characteristics of the study sample; no data were missing. The sample had an average age of 76.7 AE 5.2, was highly educated (15.0 AE 2.9 years), and had a higher than average preoperative general cognitive performance score (57.6 AE 7.3). Fifty-eight percent of the study sample was female. Eighty-one percent of participants underwent orthopedic surgery, 87% had general anesthesia, 12% had a Charlson Comorbidity Index of 3 or greater, 8% had preoperative connective tissue disease, and 11% had a postoperative infectious complication. Twenty-four percent of the study sample developed postoperative delirium, 12% had 2 or more delirium days, and the average sum CAM-S was 9.3 AE 11.4. Figure 1 plots the distribution of preoperative and POD2 CRP. There was a strong effect of surgery on CRP, with POD2 CRP levels nearly 100 times as high as preoperative levels. Figure 2 illustrates the median levels and interquartile range for preoperative and POD2 CRP levels according to postoperative delirium status (no delirium, SSD, delirium). Figure 2A suggests a threshold effect, with high preoperative CRP only in the delirium group. Figure 2B shows increasing POD2 CRP levels across the delirium categories (no delirium, subsyndromal delirium, and delirium), suggesting a dose-response relationship. Table 2 shows the relative risk of postoperative delirium according to preoperative and POD2 CRP quartiles examined in separate models. Unadjusted and adjusted models yielded similar results, indicating a significant association between CRP (preoperative and POD2) and postoperative delirium (only results for adjusted models shown). After adjusting for age, sex, surgery type, anesthesia route, preoperative Charlson Comorbidity Index, and postoperative infectious complications, participants with preoperative CRP values in quartile (Q)4 had a significantly greater risk of developing postoperative delirium than those in Q1, with a significant trend of increasing risk across the CRP quartiles. Finally, participants with preoperative CRP levels of 3 mg/L or more were 1.5 times as likely to develop delirium than those with CRP levels less than 3 mg/L.
RESULTS
Participants with POD2 CRP levels in Q4 had greater risk of postoperative delirium than those in Q1, with a significant trend of increasing risk across CRP quartiles. Exclusion of 131 participants taking medications that might influence CRP levels, including steroids, nonsteroidal antiinflammatory drugs, and immune modulators, did not change these findings. Higher CRP quartile was generally associated with greater risk of developing SSD, but this association was not statistically significant (Table S1) . Table 2 also reports the associations between CRP and delirium duration and feature severity. All models yielded consistently strong associations between CRP and delirium days and delirium feature severity. Participants with CRP values in the highest quartile (Q4) for preoperative and POD2 CRP had more delirium days. For instance, participants in Q4 for preoperative CRP had almost one half more delirium day and had sum CAM-S scores that were 3.6 points higher than those in Q1. There was also a significant delirium days and feature severity (see p-trend values in Table 2 ). Similar to the findings for sum CAM-S, higher CRP at both time points was associated with higher peak CAM-S scores (Table S2) . Table 3 shows the relative risk of LOS and discharge to a post-acute facility according to CRP (preoperative and POD2). Participants with preoperative CRP in Q4 were 1.7 times as likely to have a prolonged LOS (>5 days) than those in Q1. This greater risk was also observed for participants with preoperative CRP levels of 3 mg/L or higher, who were 1.4 times as likely to have a LOS longer than 5 days than those with with CRP levels less than 3 mg/L. Higher CRP on POD2 was associated with greater risk of having a prolonged LOS (P-trend = .03) and greater risk of discharge to a post-acute facility (P-trend = .04). Table S3 reports the prevalence of the Inouye delirium risk score factors according to delirium status, and Appendix 2 reports results for the prediction analyses.
Added Prediction Analyses
DISCUSSION
In this study of older adults without dementia undergoing elective major noncardiac surgery, significant associations between preoperative and POD2 CRP levels and delirium incidence, duration, and feature severity were observed. Participants with high levels of preoperative (and POD2) CRP had greater delirium incidence, longer delirium duration, and more-severe delirium than those with lower levels of preoperative (and POD2) CRP. Moreover, a significant dose-response relationship was observed between preoperative and POD2 CRP and all three delirium outcomes, such that higher CRP was associated with worse outcomes. These results suggest that preoperative CRP may be an important risk marker for delirium incidence and that CRP measured preoperatively and on POD2 may aid in predicting and monitoring the severity of postoperative delirium.
A current model of delirium pathophysiology proposes that individuals predisposed to a heightened inflammatory response when exposed to an acute stressor (e.g., surgery or infection) are at greater risk of delirium. 29, 30 It is postulated that, under certain conditions, systemic inflammatory mediators cross the blood-brain barrier, activate brain microglia, and initiate neuroinflammation. 28 This model has gained substantial attention in recent years, 31 and these findings linking CRP with delirium incidence and feature severity lend support to the role of systemic inflammation in delirium pathophysiology. Moreover, emerging evidence from animal models 31 and human studies 32 suggests that heightened systemic inflammation may affect the brain. For instance, several studies have demonstrated that animals killed after being exposed to systemic inflammatory insults, such as lipopolysaccharide and Gram-negative bacteria, showed evidence of neuroinflammation on brain autopsy. In humans, increasing evidence of an association between neuroinflammation and dementia has been reported. 33, 34 Previous work, 16 a proteomics approach designed for discovery of proteins associated with delirium incidence, used a matched case-control study design of individuals with and without delirium, which imposed significant constraints on the types of analyses that could be performed. For instance, the case-control study did not consider participants with SSD and required participants with delirium to have delirium on POD2 to correspond with the time of blood draw. Although the inclusion of only carefully selected individuals with delirium and delirium-free controls allows for maximal contrast to discover biomarkers, it is not representative of the full clinical cohort. The current study substantially extends this previous work by examining the association between preoperative CRP and delirium incidence in a more clinically representative surgical sample, including individuals with SSD, and examining four additional outcomes: delirium duration, delirium feature severity, LOS, and discharge to a post-acute facility. Additional strengths of this study include the consistent findings for all four outcomes and evidence of a doseresponse effect, which underscores the robustness of the results and strengthens the conclusion of an association between CRP (preoperative and POD2) and delirium.
This study adds new, clinically relevant information to the literature on CRP and delirium. CRP might be a useful marker for risk stratification of individuals before major surgery given its observed association with delirium incidence, duration, feature severity, and prolonged LOS. In particular, the addition of CRP preoperatively and on POD2 to the Inouye delirium risk score 28 significantly improved the predictive model, lending further support for the use of CRP to identify individuals who may benefit from proactive interventions. It was not the primary aim to examine the association between CRP and LOS and discharge disposition; rather, these were added as secondary outcomes to support the association between CRP and delirium. Nonetheless, the findings of the association between CRP and these outcomes are interesting and warrant further exploration in future studies.
Some limitations of the study warrant mention. First, the analyses were limited to examination of a single marker of inflammation: CRP. Although CRP is the most clinically used summary marker of inflammation, it will be important to examine the associations between other, more-specific markers of inflammation (e.g., cytokines) and delirium incidence and feature severity, in addition to examining their joint effects. A priority area for future research will be to explore the synergistic effects of multiple inflammatory markers on delirium incidence and feature severity. Second, the availability of blood on POD2 may not align with delirium occurring several days after surgery. Third, a detailed examination of postoperative medication use and its influence on inflammation and delirium is beyond the scope of the current manuscript. In future work, there are plans to conduct detailed pharmacoepidemiological analyses to address this important question. Fourth, these findings may not be generalizable to the overall population of older adults undergoing major scheduled surgery because adults without dementia from two academic medical centers in one geographic region were enrolled, and minority representation was low. Future studies with more-diverse samples are required. Contrary to expectations, no association was found between CRP and SSD, but the small size of this group in the sample limited power. f No high-risk cutpoint analysis was completed for CRP at POD2 because the scores are much higher than those in prior (community based) samples.
In conclusion, high preoperative and POD2 CRP levels were associated with delirium incidence, duration, and feature severity. If these findings are validated in future studies, CRP may be useful clinically to stratify individuals at risk of delirium before surgery and to track its severity. These findings also provide robust support for the role of inflammation in delirium pathophysiology and may motivate development of new pathophysiologically based intervention strategies to prevent and treat this common, morbid, costly geriatric syndrome that threatens the independence of older adults. Please note: Wiley-Blackwell is not responsible for the content, accuracy, errors, or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.
